Skip to main content

Barwon Health / Research

(03) 4215 0000

Our Investigators

Contact

Medical Speciality

Interest Areas

Experience

A/Prof John Amerena

Ph (03) 4215 1025

email.png

Cardiology

  • Heart failure
  • Cardiovascular disease
  • Diabetes
  • Hypertension
  • Atrial fibrillation
  • Dyslipidemia

More than 25 years' experience in cardiovascular studies. Both inpatient and outpatient cardiovascular outcome studies, including acute coronary syndrome, heart failure, diabetes, dyslipidaemia, atrial fibrillation and hypertension.

Prof Eugene Athan

Ph (03) 4215 2375

email.png

Infectious Diseases

  • Vaccines
  • Antivirals
  • Antimicrobials
  • Healthcare infections/device infections
  • Staphylococcus aureus

Over 15 years of active research and clinical trials experience as principal investigator on phase 1 b to phase 3 trials.

Prof Michael Berk

Ph (03) 4215 3320

email.png

Psychiatry

  • Treatment of mental disorders
  • Neuroprotection, neuroprogression and clinical staging
  • Biological markers
  • Drug discovery
  • Onset and course of mental illness

Over 20 years of research experience in mental health. Esteemed clinician and academic.

Dr Adam Broad

Ph (03) 4215 2700

email.png

Medical Oncology

  • Lung cancer / primary  thoracic cancers
  • Melanoma
  • Colo-rectal cancer
  • Upper gastro-intestinal cancer (incl pancreatic)
  • Merkel cell cancer

Prior oncology clinical trials fellow (2004) during specialist training. Principal investigator in approximately 40 trials over 15 years via Barwon Health. Member of ALTG /  IASLC / AGITG.

David Campbell

email.png

Medical Oncology

  • Uro-oncology
  • Breast cancer
  • CNS/Glioma

Clinical research experience over 10 years. Involved in phase 1,2 and 3 trials. Experience as principle investigator in trials including prostate, renal, bladder cancer, breast and gliomas.

A/Prof Philip Campbell

Ph (03) 4215 2751

email.png

Clinical Haematology and Stem Cell Transplantation

  • Multiple myeloma
  • Chronic lymphocytic leukaemia
  • Lymphoma
  • Acute myeloid leukaemia
  • Immune thrombocytopenia

More than 20 years' experience as a clinician researcher involved in investigator-initiated, cooperative group and sponsored phase I, 2 and 3 trials.

A/Prof Olivia Dean

Ph (03) 4215 3300

email.png

Psychiatric Clinical Trials

Affective Disorders Research

  • Treatment of mental disorders
  • Novel therapies
  • Underlying biology of affective disorders
  • Placebos
  • Treatment response and non-response

Over 15 years' research experience in mental health. 2019 Web of Science highly cited researcher.

A/Prof Seetal Dodd

Ph (03) 4215 3299

email.png

Psychopharmacology

Pharmacokinetics

Drug metabolism Drug safety

  • Treatment of mental disorders
  • Neuroprotection, neuroprogression and clinical staging
  • Tobacco smoking cessation
  • Placebos
  • Onset and course of mental illness

Over 20 years' research experience in mental health, ranging from pre-clinical drug development to level 2 and 4 clinical trials.

Rachel Fiddes

Ph 0411 399 025

email.png

Anaesthesia and Pain

  • Research, anaesthetics & recovery

Anaesthetics clinical trials.

Dr Melissa Formica

Ph 0411 399 025

email.png

Anaesthesia and Pain

  • Prevention of post-operative cognitive dysfunction

Focus of research being the effect of lifestyle factors on cognitive function in older adults. Extensive experience running research trials and has worked at Barwon Health for more than two years as a research fellow, coordinating multiple research trials.

Dr Michael Francis

Ph (03) 4215 2746

Radiation Oncology

  • Breast cancer
  • Lymphoma
  • CNS tumours
  • Lung cancer

More than 18 years' involvement with TROG, ANZ Breast Cancer Trials Group, COGNO Trials Group.

Dr Adam Friebe

email.png

Haematology

  • Coagulation
  • Immune thrombocytopenia
  • Aplastic Anaemia

Involvement in numerous clinical trials since clinical registrar (2011) - lymphoma, CML, thrombocytopenia, therapeutic anticoagulation, ITP. Potential involvement in upcoming aplastic anaemia.

Dr David Fuller

email.png

Paediatrics

  • Paediatrics
  • Paediatric infectious diseases

Six years' experience as a principal investigator and co-investigator on paediatric clinical trials both commercially sponsor trials, including early phase trials in RSV, bacteremia and osteomyelitis.

Dr Claire Furyk

Ph (03) 4215 1901

Anaesthesia

  • Improving outcomes in the high risk surgical patient
  • Frailty and surgery
  • Paediatric anaesthesia
  • Continuous quality improvement

Principal investigator on small single centre studies published in 2018. Principal site investigator and associate site investigator on several ongoing multicentre trials in anaesthesia.

Ian Grant

email.png

Palliative Care
  • Symptom management
Trial investigator for trials related to pain, nausea, breathlessness, delirium, cachexia.

Dr Andrew Hui

Ph (03) 4215 2746

email.png

Radiation Oncology

  • Lung
  • Skin and melanoma
  • Head and neck
  • Upper GI

Nineteen years' experience as a radiation oncologist. Recruited patients into various trials over the years.

Dr. Andrew Iliov

email.png

Anaesthesia and Perioperative Medicine

  • Perioperative outcomes
  • Sustainability in health careMedical education and simulation

 

Prof Felice Jacka

Nutritional Psychiatry

  • Psychiatry
  • Nutrition and dietetics
  • Fecal transplants
  • Gut microbiota

Dietary intervention - The SMILES trial (2012-2016)

Moving Moods - FMT for major depressive disorder (2020-2023);

Moo'D trial: A2 versus Conventional dairy for mood and cognition.

Prof  Mark Kotowicz

Ph (03) 4215 2899

email.png

Endocrinology

  • Osteoporosis
  • Diabetes
  • Dyslipidaemia
  • Obesity
  • Musculoskeletal disease

Over 45 years' experience in clinical investigation including studies concerning the pathogenesis, pathophysiology, epidemiology, diagnosis and treatment of osteoporosis, treatment of Paget’s disease of bone, treatment of Type 1 and Type 2 diabetes and their complications, including cardiovascular outcome studies, management of dyslipidaemia in diabetes and medical therapy of obesity. Principal investigator or co-investigator in over 80 industry and investigator-initiated phase 2-4 clinical trials. Over 200 publications in the peer-reviewed literature.

Dr Anna Lomax

Medical Oncology

  • Melanoma
  • Lung

Trial fellow at Eastern Health 2013-2014. Phase 2-3. Melanoma/phase 1 fellow at Chris O'Brien Lifehouse. 2015-2016. Phase 1-3. Oncologist at University Hospital Geelong, melanoma, lung and GU clinical trials. Phase 2-3.

Dr Matthew Maiden

Head of ICU Research

Contact: Allison Bone

ICU Research Coordinator

Ph 0403 603 545

email.png

Intensive Care

  • Nutrition
  • Ventilation
  • Sepsis
  • Musculoskeletal outcomes
  • Patient reported outcomes

An intensive care research department with experience in investigator initiated phase 2 and 3 clinical trials.

Andrew Marriott

email.png

Anaesthesia, Perioperative Medicine and Pain

  • Perioperative cognition
  • Chronic post surgical pain
  • Post operative nausea and vomiting
  • Perioperative anaemia

Site principal investigator, local and national perioperative clinical trials.

Peter Martin

email.png

Palliative Care
  • Cancer Cachexia
  • Healthcare communication
Leading a dedicated Cachexia service for 15 years. Teaching healthcare communication for 25 years.

Dr Maitham Mathlum

Ph (03) 4215 5166

email.png

Radiation Oncology

  • Prostate and urological cancers
  • Upper GIT mainly Oesophageal- Gastric cancers
  • Head and neck cancer
  • Combined modality (Immunotherapy ,molecular therapy with Radiotherapy)
  • New technology (precision, focal radiotherapy)

Senior radiation oncologist with 14 years’ experience oncological trials. Principle investigator for several international and local trials. Member of EORTC, TROG trial group.

Dr Shannon McCarthy

email.png

Endocrinology

  • Diabetes
  • Osteoporosis
  • Obesity
  • Paget's disease
  • Infectious diseases

Five years experience as sub-investigator and now principal investigator on international phase II-RCTs in diabetes, osteoporosis, Paget's disease, and obesity.

Dr Kate McCloskey

email.png

Paediatrics

  • Paediatrics
  • Neonates

More than 6 years' experience as an investigator on paediatric clinical trials, for both commercially sponsor and investigator initiated trials, including early phase trials in RSV, bacteremia and osteomyelitis.

Dr Inger Olesen

email.png

Oncologist

  • Gynaecological malignancies
  • Lung & other thoracic tumours
  • Breast cancer
  • Colorectal & upper GI tumours
  • Early phase trials

Over 10 years' experience as a PI and SubI in trials (phase 1-3).

Prof Richard Page

Contact: Sally Beattie

Orthopaedic Research Manager

Ph (03) 4215 2208

email.png

Orthopaedics

Musculoskeletal Sciences

  • Shoulder surgery and outcomes
  • Joint replacement surgery and joint registry trials
  • Orthopaedic trauma
  • Musculoskeletal disease gene expression
  • Bone and tissue banking

Thromboprophylaxis trials phase 2b and 3 (2001–ongoing). Multicentre and international trauma outcome trials (2003-ongoing). Shoulder, hip and knee replacement outcomes - RCTs – phase 3+ (2009-ongoing). Antibiotic usage in orthopaedic infection RCT. Analgesia in orthopaedic surgery RCTs (phase 2 and 3).

Dr Mark Perrin

Cardiologist and Electrophysiologist

  • Inherited arrhythmia syndromes
  • Conduction system pacing (His Bundle and Left Bundle Branch Pacing)
  • Sudden cardiac death
  • Atrial fibrillation

Post-doctoral research in Ottawa, Canada. Clinical fellowship Ottawa, Canada for two years, six years in Geelong.

Dr Sumi Ratnasingam

email.png

Haematology

  • Aggressive lymphoma
  • Low grade/indolent lymphoma
  • Myeloma
  • Acute leukaemia
  • All remaining malignant haematology trials

Malignant haematology clinical trials fellow at Monash Haematology for two years. Sub-investigator for 40+ trials and in charge of managing many of these malignant trials ranging from phase 1b to phase 3 trials. Clinical haematologist and investigator for trials at Andrew Love Cancer Centre (ALCC). PI for B-MIND (phase III), HARBOUR (Phase 1b-II) and HMPL-523 (phase 1-II) clinical trials. SI for all other remaining trials. Honorary haematologist and sub-investigator for aggressive lymphoma trials including CAR T studies at Peter MacCallum Cancer Centre (2019-current).

Hannah Rose

 email.png

Haematology

  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Myeloma
  • CLL
  • Myeloproliferative Neoplasms

Over six years' experience as an investigator on over 20 clinical trials, including as principal investigator on large international phase 3 trials in Hodgkins and Non-Hodgkins lymphoma. Results from these trials have been presented at international conferences and in peer reviewed journals.

Dr Cameron Shaw

Ph (03) 42150710

email.png

Neurology

  • Multiple Sclerosis
  • Neuroimmunology

Local principal investigator for several multicentre RCTs and observational studies of disease-modifying therapies in Multiple Sclerosis. Collaborator in large scale epidemiological studies (e.g. AUSImmune, MSBase).

Madhu S Singh

email.png

Medical Oncology

  • Head and neck
  • Upper GI
  • Lower GI
  • General Oncology
  • Uro Oncology

Thirteen years' experience. Interest in Phase 1. 2 ,3 trials.

Dr Shu Fen Wong

email.png

Medical Oncology

  • Gastrointestinal
  • Lung

Five clinical years as a specialist; experience with phase 1 trials as a trials fellow at Royal Melbourne Hospital in 2012; now have experience with phase 2 and 3 trials at University Hospital Geelong.

A/Prof Daniel O’Brien

Ph (03) 4215 2375

email.png

Infectious Diseases

  • Mycobacteria
  • HIV
  • Travel medicine
  • Immigrant/refugee health
  • COVID-19

Clinical research

 

 

Last Modified: Monday, 06 July 2020